Determination of ppar activity in adipose tissue and spleen

Journal of Immunoassay and Immunochemistry

Volumn 33, Issue 3, 2012, Pages 314-324

  Chan, Siu Lung ^a   Cipolla, Marilyn J ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

immunoassay; peroxisome proliferator activated receptor gamma; rosiglitazone

Indexed keywords

CD36 ANTIGEN; LIVER X RECEPTOR ALPHA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TISSUE EXTRACT;

ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GENE EXPRESSION; IMMUNOASSAY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SPLEEN; TISSUE HOMOGENATE; ANIMAL; COMPARATIVE STUDY; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT;

ADIPOSE TISSUE; ANIMALS; FEMALE; GENE EXPRESSION; IMMUNOASSAY; POLYMERASE CHAIN REACTION; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN;

EID: 84863460888     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321819.2011.647189     Document Type: Article

References (25)

1. Berger, J. P.; Akiyama, T. E.; Meinke, P. T. PPARs: Therapeutic targets for metabolic disease. Trends Pharmacol. Sci. 2005, 26(5), 244-251.
2. Hsueh, W. A.; Bruemmer, D. Peroxisome proliferator-activated receptor gamma: Implications for cardiovascular disease. Hypertension 2004, 43(2), 297-305.
3. Hsueh, W. A.; Law, R. E. PPARgamma and atherosclerosis: Effects on cell growth and movement. Arterioscler=Thromb. Vasc. Biol. 2001, 21(12), 1891-1895.
4. Kersten, S.; Desvergne, B.; Wahli, W. Roles of PPARs in health and disease. Nature 2000, 405(6785), 421-424.
5. Duan, S. Z.; Usher, M. G.; Mortensen, R. M. PPARs: The vasculature, inflammation and hypertension. Curr. Opin. Nephrol. Hypertens. 2009, 18(2), 128-133.
6. Day, C. Thiazolidinediones: A new class of antidiabetic drugs. Diabet. Med. 1999, 16(3), 179-192.
7. Chawla, A.; Schwarz, E. J.; Dimaculangan, D. D.; Lazar, M. A. Peroxisome proliferator-activated receptor (PPAR) gamma: Adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 1994, 135(2), 798-800.
8. Braissant, O.; Foufelle, F.; Scotto, C.; Dauca, M.; Wahli, W. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha,-beta, and-gamma in the adult rat. Endocrinology 1996, 137(1), 354-366.
9. Garcia-Bueno, B.; Madrigal, J. L.; Perez-Nievas, B. G.; Leza, J. C. Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats. Endocrinology 2008, 149(4), 1969-1978.
10. Sobrado, M.; Pereira, M. P.; Ballesteros, I.; Hurtado, O.; Fernandez-Lopez, D.; Pradillo, J. M.; Caso, J. R.; Vivancos, J.; Nombela, F.; Serena, J.; Lizasoain, I.; Moro, M. A. Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke. J. Neurosci. 2009, 29(12), 3875-3884.
11. Gerhold, D. L.; Liu, F.; Jiang, G.; Li, Z.; Xu, J.; Lu, M.; Sachs, J. R.; Bagchi, A.; Fridman, A.; Holder, D. J.; Doebber, T. W.; Berger, J.; Elbrecht, A.; Moller, D. E.; Zhang, B. B. Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists. Endocrinology 2002, 143(6), 2106-2118.
12. Singh, S.; Bennett, R. G. Relaxin signaling activates peroxisome proliferator-activated receptor gamma. Mol. Cell. Endocrinol. 2010, 315(1-2), 239-245.
13. Motojima, K.; Passilly, P.; Peters, J. M.; Gonzalez, F. J.; Latruffe, N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue-and inducer-specific manner. J. Biol. Chem. 1998, 273(27), 16710-16714.
14. Juvet, L. K.; Andresen, S. M.; Schuster, G. U.; Dalen, K. T.; Tobin, K. A.; Hollung, K.; Haugen, F.; Jacinto, S.; Ulven, S. M.; Bamberg, K.; Gustafsson, J. A.; Nebb, H. I. On the role of liver X receptors in lipid accumulation in adipocytes. Mol. Endocrinol. 2003, 17(2), 172-182.
15. Cipolla, M. J.; Smith, J.; Kohlmeyer, M. M.; Godfrey, J. A. SKCa and IKCa channels, myogenic tone, and vasodilator responses in middle cerebral arteries and parenchymal arterioles: Effect of ischemia and reperfusion. Stroke 2009, 40(4), 1451-1457.
16. Livak, K. J.; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25(4), 402-408.
17. Thuillier, P.; Baillie, R.; Sha, X.; Clarke, S. D. Cytosolic and nuclear distribution of PPARgamma2 in differentiating 3T3-L1 preadipocytes. J. Lipid Res. 1998, 39(12), 2329-2338.
18. Clark, R. B.; Bishop-Bailey, D.; Estrada-Hernandez, T.; Hla, T.; Puddington, L.; Padula, S. J. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J. Immunol. 2000, 164(3), 1364-1371.
19. Guri, A. J.; Mohapatra, S. K.; Horne, W. T., II; Hontecillas, R.; Bassaganya-Riera, J. The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease. BMC Gastroenterol. 2010, 10, 60-72.
20. Murphy, G. J.; Holder, J. C. PPAR-gamma agonists: Therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol. Sci. 2000, 21(12), 469-474.
21. Bruck, R.; Weiss, S.; Aeed, H.; Pines, M.; Halpern, Z.; Zvibel, I. Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptor. Dig. Dis. Sci. 2009, 54(2), 292-299.
22. Knight, M. I.; Chambers, P. J. Problems associated with determining protein concentration: comparison of techniques for protein estimations. Mol. Biotechnol. 2003, 23(1), 19-28.
23. Okutucu, B.; Dincer, A.; Habib, O.; Zihnioglu, F. Comparison of five methods for determination of total plasma protein concentration. J. Biochem. Biophys. Methods 2007, 70(5), 709-711.
24. Chen, Q.; Sun, X.; Chen, J.; Cheng, L.; Wang, J.; Wang, Y.; Sun, Z. Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells. Reprod. Biol. Endocrinol. 2009, 7, 147-154.
25. Kim, K. R.; Choi, H. N.; Lee, H. J.; Baek, H. A.; Park, H. S.; Jang, K. Y.; Chung, M. J.; Moon, W. S. peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma. Oncol. Rep. 2007, 18(4), 825-832.